BackTable

Podcast #243 · 24 Jun 2025

Intermediate Risk NMIBC: Patient-Centered Treatment Strategies

Counseling patients with intermediate-risk non-muscle invasive bladder cancer can be complex, with a wide range of treatment options and care pathways. In this episode of BackTable Urology, urologic oncologists Dr. Ruchika Talwar and Dr. Kelly Bree explore how to approach this challenge with clarity and compassion.

This podcast is supported by an educational grant from UroGen Pharma.

Timestamps

Resources

You may also like

Loading
Loading
Loading
Loading

More about this episode

They emphasize a shift toward patient-centered, less aggressive treatment strategies, highlighting the importance of quality of life in clinical decision-making. The discussion includes risk stratification, the use of intravesical gemcitabine, and ongoing clinical trials. Dr. Bree also offers actionable tips for optimizing patient preparation and recovery. This episode underscores the growing importance of listening to patient voices to shape future standards of care.